Boston Scientific Corp (BSX) stock
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3050% below fair value
$44.20−0.93 (-2.06%)
Close on Nov 12, 2026Market cap $64.06BP/E 18.7Yield –
Boston Scientific statistics
96 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 3, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1884.00
- 4.85
- P/OCF Ratio
- 15.13
- 22.12
Enterprise valuationIndustry
- EV / Sales
- 3.59
- 2.70
- EV / EBIT
- 19.24
- 24.04
- EV / FCF
- 22.71
- 27.78
Share statisticsIndustry
- Shares Change (YoY)
- -0.91%
- 3.22%
- Float
- 1.45B
- 37M
- Shares Held by Insiders
- 0.20%
- 10.5%
- Shares Held by Institutions
- 92.1%
- 60.2%
Short sellingIndustry
- Short Interest
- 35M
- –
- Short Interest Change
- -13.7%
- -2.57%
- Short % of Float
- 2.43%
- 5.12%
- Short % of Shares Outstanding
- 2.42%
- 3.98%
- Days to Cover
- 1.65
- 3.94
Stock price statisticsIndustry
- 52-Week High
- $105.65
- –
- 52-Week Low
- $39.57
- –
- 20-Day Moving Average
- $44.40
- –
- 50-Day Moving Average
- $44.06
- –
- 200-Day Moving Average
- $54.38
- –
- Average True Range (14)
- $1.77
- –
- Price Change (1 Week)
- -0.99%
- 2.01%
- Price Change (1 Month)
- 2.79%
- -0.57%
- Price Change (3 Months)
- -14.7%
- -7.91%
- Price Change (6 Months)
- -17.5%
- -0.90%
- Price Change (YTD)
- -53.6%
- -0.82%
- Price Change (1 Year)
- -56.9%
- -1.18%
- Price Change (3 Years)
- -17.7%
- 6.56%
- Price Change (5 Years)
- 5.06%
- -49.8%
- Price Change (10 Years)
- 105.6%
- 57.3%
- Average Volume (10 Days)
- 19M
- –
- Average Volume (20 Days)
- 20M
- –
- Average Volume (90 Days)
- 20M
- –
- Relative Volume
- 0.59
- 0.82
- Relative Strength Index (14)
- 49.9
- 47.7
- Volatility (1 Year)
- 40.1%
- 64.2%
- Beta (5 Years)
- 0.78
- 1.05
MarginsIndustry
- Pretax Margin
- 17.3%
- -2.55%
- EBITDA Margin
- 25.5%
- -2.82%
- FCF Margin
- 15.8%
- 0.40%
Returns on capitalIndustry
- Return on Invested Capital (ROIC)
- 10.6%
- -3.22%
- Return on Capital Employed (ROCE)
- 9.96%
- -8.13%
Financial positionIndustry
- Current Ratio
- 1.36
- 2.45
- Quick Ratio
- 0.10
- 1.53
- Debt / Equity
- 0.47
- 0.42
- Debt / EBITDA
- 2.23
- 2.19
- Debt / FCF
- 3.59
- 3.62
- Net Debt / EBITDA
- 2.11
- 1.53
- Interest Coverage
- 10.46
- -1.68
GrowthIndustry
- Revenue Growth (YoY)
- 8.88%
- 9.24%
- EPS Growth (YoY)
- 26.2%
- 15.1%
- FCF Growth (YoY)
- -12.9%
- 7.64%
- Revenue Growth (3Y CAGR)
- 16.5%
- 7.08%
- Revenue Growth (5Y CAGR)
- 15.2%
- 11.8%
- EPS Growth (3Y CAGR)
- 62.8%
- 3.11%
EfficiencyIndustry
- Asset Turnover
- 0.48
- 0.59
- Inventory Turnover
- 2.08
- 2.20
- Revenue Per Employee
- $357.10K
- $330.60K
- Employee Count
- 59,000
- 186
- WACC
- 8.12%
- 9.71%
Income statement (TTM)Industry
- Pretax Income
- $3.66B
- -$1.69M
Balance sheetIndustry
- Net Cash (Debt)
- -$11.34B
- $3.73M
- Net Cash Per Share
- -$7.83
- $0.24
- Equity (Book Value)
- $25.63B
- $63.44M
- Book Value Per Share
- $17.69
- $3.26
- Tangible Book Value
- $34.00M
- $11.04M
- Working Capital
- $2.18B
- $56.85M
Cash flow (TTM)Industry
- Capital Expenditures
- -$903.00M
- -$3.69M
- FCF Per Share
- $2.30
- -$0.01
Dividends and yieldsIndustry
- FCF Yield
- 5.20%
- 0.24%
Taxes and interestIndustry
- Interest Expense
- $376.00M
- $5.33M
- Income Tax
- $162.00M
- $1.63M
- Effective Tax Rate
- 4.43%
- 18.3%
Scores and fair valueIndustry
- Graham Number
- $30.64
- $38.11
- Graham Upside
- -30.7%
- -56.3%
- Altman Z-Score
- 3.03
- 2.44
- Lynch Fair Value
- $59.00
- –
- Lynch Upside
- 33.5%
- -45.1%
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | BSX | S&P 500 | Difference | BSX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +0.8% | -2.7% | +3.5 pts | ||
| 3 months | -14.0% | -1.7% | −12.3 pts | ||
| Year to date | -53.6% | +11.9% | −65.5 pts | ||
| 1 year | -57.6% | +12.0% | −69.5 pts | ||
| 3 years | -14.3% | +78.2% | −92.5 pts | -5.0% | +21.2% |
| 5 years | +5.1% | +73.2% | −68.2 pts | +1.0% | +11.6% |
| 10 years | +105.6% | +309.6% | −204.1 pts | +7.5% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
35M BSX shares were sold short on Oct 30, 2026, down 13.7% from the previous report, or 2.43% of the shares available to trade. At recent volumes it would take 1.6 days to buy them back. Over the last 20 sessions, 36.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 35,113,858 | -13.7% | 21,261,859 | 1.6 |
| Oct 15, 2026 | 40,708,019 | -1.7% | 15,744,920 | 2.6 |
| Sep 30, 2026 | 41,410,512 | -11.0% | 21,984,746 | 1.9 |
| Sep 15, 2026 | 46,504,769 | -3.5% | 19,748,214 | 2.4 |
| Aug 31, 2026 | 48,173,758 | +74.4% | 21,036,931 | 2.3 |
| Aug 14, 2026 | 27,617,554 | +24.0% | 17,642,161 | 1.6 |
| Jul 31, 2026 | 22,276,201 | -21.2% | 21,974,600 | 1.0 |
| Jul 15, 2026 | 28,281,040 | +1.2% | 16,776,824 | 1.7 |
| Jun 30, 2026 | 27,938,624 | -6.1% | 23,398,673 | 1.2 |
| Jun 15, 2026 | 29,750,309 | -48.3% | 20,617,498 | 1.4 |
| May 29, 2026 | 57,491,117 | +83.0% | 25,507,630 | 2.3 |
| May 15, 2026 | 31,423,298 | +9.7% | 17,713,835 | 1.8 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?